Analysts: Momenta Pharmaceuticals Inc (MNTA.O)

MNTA.O on Nasdaq

11.72USD
19 Dec 2014
Price Change (% chg)

$-0.25 (-2.09%)
Prev Close
$11.97
Open
$11.95
Day's High
$12.07
Day's Low
$11.63
Volume
1,097,035
Avg. Vol
548,583
52-wk High
$19.90
52-wk Low
$9.38

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 19 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 2 3 3 3
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.57 1.62 1.62 1.62

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 6 29.27 47.62 12.03 82.07
Quarter Ending Mar-15 5 52.04 94.00 13.90 --
Year Ending Dec-14 7 62.15 78.69 43.10 204.59
Year Ending Dec-15 8 225.33 363.14 52.00 296.50
Earnings (per share)
Quarter Ending Dec-14 6 -0.16 0.09 -0.50 0.91
Quarter Ending Mar-15 5 0.23 1.16 -0.58 --
Year Ending Dec-14 8 -1.71 -1.45 -2.11 1.12
Year Ending Dec-15 8 1.12 2.88 -2.39 2.17

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 13.03 9.34 3.69 28.34
Quarter Ending Jun-14 11.22 10.95 0.27 2.39
Quarter Ending Mar-14 8.41 10.78 2.37 28.21
Quarter Ending Dec-13 8.53 12.75 4.22 49.50
Quarter Ending Sep-13 8.60 10.75 2.15 25.04
Earnings (per share)
Quarter Ending Sep-14 -0.43 -0.56 0.13 -29.84
Quarter Ending Jun-14 -0.46 -0.51 0.05 -9.96
Quarter Ending Mar-14 -0.55 -0.53 0.02 -4.21
Quarter Ending Dec-13 -0.45 -0.59 0.14 -30.70
Quarter Ending Sep-13 -0.48 -0.50 0.02 -3.86

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 29.27 29.27 26.44 27.43 82.07
Quarter Ending Mar-15 52.04 52.04 48.12 47.88 --
Year Ending Dec-14 62.15 62.15 59.83 63.30 204.59
Year Ending Dec-15 225.33 225.33 217.29 222.97 296.50
Earnings (per share)
Quarter Ending Dec-14 -0.16 -0.16 -0.22 -0.15 0.91
Quarter Ending Mar-15 0.23 0.23 0.18 0.15 --
Year Ending Dec-14 -1.71 -1.71 -1.75 -1.60 1.12
Year Ending Dec-15 1.12 1.12 1.05 1.12 2.17

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Dec-14 0 0 0 1
Quarter Ending Mar-15 0 0 0 1
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 2

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks